Descriptor English: | Oncogene Protein gp140(v-fms) | ||||||
Descriptor Spanish: |
Proteína Oncogénica gp140(v-fms)
| ||||||
Descriptor Portuguese: | Proteína Oncogênica gp140(v-fms) | ||||||
Descriptor French: | Protéine oncogène gp140(v-fms) | ||||||
Entry term(s): |
fms Oncogene Product gp120 fms Oncogene Product gp140 fms Oncogene Protein gp120 fms Oncogene Protein gp140 gp120 v fms gp120 v-fms gp120(v-fms) gp140 v fms gp140 v-fms gp140(v-fms) v fms Protein v-fms Protein v-fms, gp120 v-fms, gp140 |
||||||
Tree number(s): |
D12.776.624.664.520.750.650 D12.776.964.700.750.650 D12.776.964.775.750.650 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D016281 | ||||||
Scope note: | Transforming glycoprotein coded by the fms oncogene from the Susan McDonough strain of feline sarcoma virus (SM-FeSV). The oncogene protein v-fms lacks sequences, which, in the highly homologous proto-oncogene protein c-fms (CSF-1 receptor), normally serve to regulate its tyrosine kinase activity. The missing sequences in v-fms mimic the effect of ligand and lead to constitutive cell growth. The protein gp120(v-fms) is post-translationally modified to generate gp140(v-fms). |
||||||
Annotation: | IM; coord with specific virus (IM); /drug eff /ultrastruct permitted |
||||||
Allowable Qualifiers: |
AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis DE drug effects DF deficiency EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UL ultrastructure UR urine |
||||||
Previous Indexing: |
Oncogene Proteins, Viral (1985-1989) Retroviridae Proteins (1987-1989) Retroviridae Proteins, Oncogenic (1990) |
||||||
Public MeSH Note: | 91 |
||||||
History Note: | 91 |
||||||
DeCS ID: | 29067 | ||||||
Unique ID: | D016281 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 1991/01/01 | ||||||
Date of Entry: | 1990/06/19 | ||||||
Revision Date: | 2005/06/30 |
-
-
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins
|
Oncogene Protein gp140(v-fms)
- Preferred
fms Oncogene Protein gp120
- Narrower
gp120(v-fms)
- Narrower
fms Oncogene Product gp120
- Narrower
Concept UI |
M0024883 |
Scope note | Transforming glycoprotein coded by the fms oncogene from the Susan McDonough strain of feline sarcoma virus (SM-FeSV). The oncogene protein v-fms lacks sequences, which, in the highly homologous proto-oncogene protein c-fms (CSF-1 receptor), normally serve to regulate its tyrosine kinase activity. The missing sequences in v-fms mimic the effect of ligand and lead to constitutive cell growth. The protein gp120(v-fms) is post-translationally modified to generate gp140(v-fms). |
Preferred term | Oncogene Protein gp140(v-fms) |
Entry term(s) |
fms Oncogene Product gp140 fms Oncogene Protein gp140 gp140 v fms gp140 v-fms gp140(v-fms) v fms Protein v-fms Protein v-fms, gp140 |
Concept UI |
M0024881 |
Preferred term | fms Oncogene Protein gp120 |
Concept UI |
M0024882 |
Preferred term | gp120(v-fms) |
Entry term(s) |
gp120 v fms gp120 v-fms v-fms, gp120 |
Concept UI |
M0024880 |
Preferred term | fms Oncogene Product gp120 |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey